FAM215A and neoplasm: In conclusion, we herein show for the first time that the lncRNA, FAM215A, is highly expressed in HCC, where it interacts with and prevents the ubiquitination of LAMP2 to increase tumor progression and decrease doxorubicin sensitivity.